CT
CRL icon

CPF Texas’s Charles River Laboratories CRL Stock Holding History

CPF Texas’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$417K Hold
3,100
– – 0.2% 119
2018
Q2 		$348K Hold
3,100
– – 0.18% 115
2018
Q1 		$331K Hold
3,100
– – 0.17% 112
2017
Q4 		$339K Buy
+3,100
New +$337K 0.17% 116

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

CPF Texas's CRL Position: Q3 2018 in Review

CPF Texas held its Charles River Laboratories (CRL) position steady in Q3 2018 at 3,100 shares worth $417K. The position accounts for 0.2% of the portfolio, ranked #119.

CPF Texas first reported a position in CRL in Q4 2017 and has held it in 4 quarters since. 366 funds tracked by Wall St. Rank hold CRL as of Q3 2018.

  • CPF Texas held 3,100 shares of Charles River Laboratories worth $417K as of Q3 2018.
  • CPF Texas left its Charles River Laboratories share count unchanged in Q3 2018.
  • Charles River Laboratories made up 0.2% of CPF Texas's portfolio in Q3 2018, its #119 holding.
  • CPF Texas first reported a position in Charles River Laboratories in Q4 2017 and has held it in 4 quarters since.
  • 366 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2018.

Based on CPF Texas's 13F filing for Q3 2018, filed 14 Nov 2018.